Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313489286> ?p ?o ?g. }
- W4313489286 endingPage "1455" @default.
- W4313489286 startingPage "1443" @default.
- W4313489286 abstract "Aims: The feasibility of using nanoparticles derived from Glycyrrhizae radix extract (Glycyrrhiza NPs) as a vaccine adjuvant for cancer immunotherapy was evaluated. Methods: C57BL/6J mice were immunized with ovalbumin (OVA) and Glycyrrhiza NPs. After immunization, splenocytes were incubated with the H-2Kb epitope peptide of OVA (SL8) and the production of IFN-γ was evaluated. Moreover, an OVA-expressing lymphoma cell line (E.G7-OVA cells) was inoculated into mice after immunization to evaluate the antitumor effect. Results: The immunization of OVA with Glycyrrhiza NPs induced IFN-γ production and completely rejected E.G7-OVA cells. Conclusion: Glycyrrhiza NPs could prime antigen-specific CD8+ T-cells resulting in antitumor effects. Therefore, Glycyrrhiza NPs can be an effective vaccine adjuvant for cancer immunotherapy.Glycyrrhizae radix is a medical plant that contains anti-inflammatory compounds such as glycyrrhizin. Nanoparticles (NPs) derived from Glycyrrhizae radix extract induced the production of proinflammatory cytokines. Therefore, these NPs could be used as a vaccine adjuvant. Here, a feasibility study on the use of Glycyrrhiza NPs as a vaccine adjuvant in cancer immunotherapy is reported. T-cell responses and antitumor effects were evaluated after the immunization of ovalbumin (OVA) with Glycyrrhiza NPs. The immunization of OVA with Glycyrrhiza NPs effectively induced OVA-specific T-cells and completely rejected OVA-expressing tumor cells. Therefore, Glycyrrhiza NPs could induce antitumor immunity and be an effective vaccine adjuvant in cancer immunotherapy." @default.
- W4313489286 created "2023-01-06" @default.
- W4313489286 creator A5006394034 @default.
- W4313489286 creator A5013270449 @default.
- W4313489286 creator A5032796186 @default.
- W4313489286 creator A5034017533 @default.
- W4313489286 creator A5076758494 @default.
- W4313489286 date "2022-12-01" @default.
- W4313489286 modified "2023-10-18" @default.
- W4313489286 title "Feasibility study of novel nanoparticles derived from <i>Glycyrrhizae radix</i> as vaccine adjuvant for cancer immunotherapy" @default.
- W4313489286 cites W1651809791 @default.
- W4313489286 cites W1901657789 @default.
- W4313489286 cites W1927575600 @default.
- W4313489286 cites W1976416996 @default.
- W4313489286 cites W1982895831 @default.
- W4313489286 cites W2013469022 @default.
- W4313489286 cites W2016671320 @default.
- W4313489286 cites W2043793366 @default.
- W4313489286 cites W2047225250 @default.
- W4313489286 cites W2064656497 @default.
- W4313489286 cites W2067701421 @default.
- W4313489286 cites W2086404290 @default.
- W4313489286 cites W2090994296 @default.
- W4313489286 cites W2095161443 @default.
- W4313489286 cites W2096729904 @default.
- W4313489286 cites W2098013424 @default.
- W4313489286 cites W2105251923 @default.
- W4313489286 cites W2142351770 @default.
- W4313489286 cites W2412922914 @default.
- W4313489286 cites W2567639438 @default.
- W4313489286 cites W2592699639 @default.
- W4313489286 cites W2904802348 @default.
- W4313489286 cites W2941766873 @default.
- W4313489286 cites W3005104290 @default.
- W4313489286 cites W3005106351 @default.
- W4313489286 cites W3012283572 @default.
- W4313489286 cites W3017240959 @default.
- W4313489286 cites W3028481751 @default.
- W4313489286 cites W3028510355 @default.
- W4313489286 cites W3028960763 @default.
- W4313489286 cites W3166751072 @default.
- W4313489286 cites W3177909407 @default.
- W4313489286 cites W3196841909 @default.
- W4313489286 doi "https://doi.org/10.2217/imt-2022-0179" @default.
- W4313489286 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36597713" @default.
- W4313489286 hasPublicationYear "2022" @default.
- W4313489286 type Work @default.
- W4313489286 citedByCount "0" @default.
- W4313489286 crossrefType "journal-article" @default.
- W4313489286 hasAuthorship W4313489286A5006394034 @default.
- W4313489286 hasAuthorship W4313489286A5013270449 @default.
- W4313489286 hasAuthorship W4313489286A5032796186 @default.
- W4313489286 hasAuthorship W4313489286A5034017533 @default.
- W4313489286 hasAuthorship W4313489286A5076758494 @default.
- W4313489286 hasConcept C142724271 @default.
- W4313489286 hasConcept C203014093 @default.
- W4313489286 hasConcept C204787440 @default.
- W4313489286 hasConcept C2776332754 @default.
- W4313489286 hasConcept C2776946954 @default.
- W4313489286 hasConcept C2777701055 @default.
- W4313489286 hasConcept C2777863537 @default.
- W4313489286 hasConcept C2778993495 @default.
- W4313489286 hasConcept C2780674031 @default.
- W4313489286 hasConcept C2780801004 @default.
- W4313489286 hasConcept C71924100 @default.
- W4313489286 hasConcept C8891405 @default.
- W4313489286 hasConcept C98274493 @default.
- W4313489286 hasConceptScore W4313489286C142724271 @default.
- W4313489286 hasConceptScore W4313489286C203014093 @default.
- W4313489286 hasConceptScore W4313489286C204787440 @default.
- W4313489286 hasConceptScore W4313489286C2776332754 @default.
- W4313489286 hasConceptScore W4313489286C2776946954 @default.
- W4313489286 hasConceptScore W4313489286C2777701055 @default.
- W4313489286 hasConceptScore W4313489286C2777863537 @default.
- W4313489286 hasConceptScore W4313489286C2778993495 @default.
- W4313489286 hasConceptScore W4313489286C2780674031 @default.
- W4313489286 hasConceptScore W4313489286C2780801004 @default.
- W4313489286 hasConceptScore W4313489286C71924100 @default.
- W4313489286 hasConceptScore W4313489286C8891405 @default.
- W4313489286 hasConceptScore W4313489286C98274493 @default.
- W4313489286 hasIssue "18" @default.
- W4313489286 hasLocation W43134892861 @default.
- W4313489286 hasLocation W43134892862 @default.
- W4313489286 hasOpenAccess W4313489286 @default.
- W4313489286 hasPrimaryLocation W43134892861 @default.
- W4313489286 hasRelatedWork W2063463358 @default.
- W4313489286 hasRelatedWork W2073312739 @default.
- W4313489286 hasRelatedWork W2205292570 @default.
- W4313489286 hasRelatedWork W2626296548 @default.
- W4313489286 hasRelatedWork W2772568294 @default.
- W4313489286 hasRelatedWork W2994886667 @default.
- W4313489286 hasRelatedWork W31129911 @default.
- W4313489286 hasRelatedWork W4221129826 @default.
- W4313489286 hasRelatedWork W4293101997 @default.
- W4313489286 hasRelatedWork W4313489286 @default.
- W4313489286 hasVolume "14" @default.
- W4313489286 isParatext "false" @default.
- W4313489286 isRetracted "false" @default.